Skip to main content
Premium Trial:

Request an Annual Quote

AlphaGene Names Schad Chief Scientific Officer


WOBURN, Mass.--Peter Schad, former vice-president of bioinformatics and biotechnology and principal investigator for the Genome Sequence Database Project at the National Center for Genome Resources, has been appointed to the position of chief scientific officer at AlphaGene.

AlphaGene is a privately held service and research-based company with the capability to produce gene libraries containing full-length cDNA genes that include complete protein-encoding sequences. John Connolly, AlphaGene's chairman, said Schad's bioinformatics experience will "help provide the needed vision to make AlphaGene a leading functional genomics and proteomics organization."

Filed under

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.